Baxter announces CE mark of new Evo IQ Infusion System in the UK and Ireland


User-friendly infusion system built to deliver intuitive clinical workflows and help optimise clinician efficiency” Baxter (2018).

Baxter report “COMPTON, Berkshire, UK, September 7, 2018 – Baxter Healthcare Ltd, a leader in innovative technology for medication delivery, has announced the CE marking of the Evo IQ Infusion System in the UK and Ireland, along with the recent regulatory approval in Australia. This represents the first in a series of planned regulatory submissions for the Evo IQ Infusion System in countries around the world, with commercial launch activities starting in the third quarter of 2018.
The Evo IQ Infusion System features a scalable platform and user-centric design that includes an advanced drug library and dose error reduction software to promote patient safety; intuitive clinical workflows to help optimise clinician efficiency; and Baxter’s One Set technology, which allows clinicians to easily switch between gravity and pump applications without changing sets, reducing disconnects and set changes and may help reduce opportunities for touch contamination, along with helping to reduce IV tubing use and costs.”

You may also be interested in…

Full Press Release


Comments are closed.